NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
The collaboration aims to combine NewGen's technical expertise in fertility treatments with BOBCARE's market resources in the region. This strategic partnership is anticipated to contribute to NewGen's market presence over the next three years, improving the competitive position of both parties in the Kyrgyzstan market. Both companies will work together on several initiatives, including enhancing clinical protocols and patient management systems, knowledge exchange between fertility specialists, coordinated marketing and brand-building activities in Kyrgyzstan, and developing specialized fertility treatment options for the regional market.
Kyrgyzstan represents a developing market for fertility services in Central Asia. The country has shown interest in healthcare investments, alongside a developing demand for advanced reproductive technologies. Kyrgyzstan has a relatively young population with evolving perspectives on fertility treatments. The collaboration aligns with ongoing economic cooperation between China and Kyrgyzstan, which have strengthened their ties as important trade partners and sources of investment under the "One-Belt-One-Road" national cooperative framework. BOBCARE, which has recently expanded its operations in Kyrgyzstan, brings valuable local market insights and established networks. NewGen contributes its international experience in fertility treatments and technical capabilities developed across its Asian operations.
'This collaboration with BOBCARE represents a strategic opportunity to extend our services to an emerging market with significant growth potential,' said Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen. 'By combining our clinical expertise with BOBCARE's regional presence, we believe we can effectively address the increasing demand for quality fertility treatments in Kyrgyzstan while creating value for our shareholders.'
Mr. Shi Lei, CEO of BOBCARE, added, 'Our strategic partnership with NewGen marks a significant step forward in BOBCARE's globalization endeavors. Through this collaboration, we are committed to introducing China's elite reproductive healthcare professionals and cutting-edge technologies to Central Asia, enhancing our ability to provide patients with an unparalleled range of high-quality fertility treatment options.'
About NewGen
NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen's management team collectively has over a decade of experience in the fertility industry. NewGen's clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen's website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
About BOBCARE
BOBCARE is a leading reproductive health and assisted reproduction service platform in China. Leveraging a high-standard service system, extensive market experience, and a wide user base, BOBCARE is dedicated to providing high-quality assisted reproduction services to users in China and globally, while continually promoting industry innovation and development. Initially funded by Matrix Partners, BOBCARE later received strategic investment from WeDoctor Group, a leading player in the field valued at $6.7 billion. Following internal restructuring within WeDoctor Group, BOBCARE emerged as a key player in the field of maternal and infant health. Since 2024, BOBCARE has shifted its focus to Kyrgyzstan, increasing investments and expanding operations in the region.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words 'believe,' 'project,' 'expect,' 'anticipate,' 'estimate,' 'intend,' 'strategy,' 'future,' 'opportunity,' 'plan,' 'may,' 'should,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's future commercial operations, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the ability of the Company and BOBCARE to successfully implement the planned initiatives in Kyrgyzstan, including the enhancement of clinical protocols, patient management systems, and knowledge exchange programs, the effectiveness of the coordinated marketing and brand-building efforts in establishing a strong market presence in Kyrgyzstan, the evolving perspectives and cultural attitudes toward fertility treatments in Kyrgyzstan, which could influence patient demand and treatment adoption, and the reliance on the strategic partner's market resources and local expertise, which may not yield the anticipated results. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company's annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
ICR, LLCRobin YangPhone: +1 (212) 537-4406Email: Newgenivf.IR@icrinc.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
28 minutes ago
- Business Insider
Stifel Nicolaus Reaffirms Their Buy Rating on Proficient Auto Logistics, Inc. (PAL)
In a report released on August 15, J. Bruce Chan from Stifel Nicolaus maintained a Buy rating on Proficient Auto Logistics, Inc., with a price target of $13.00. The company's shares closed yesterday at $7.77. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bruce Chan covers the Industrials sector, focusing on stocks such as Forward Air, XPO, and Hub Group. According to TipRanks, Bruce Chan has an average return of 0.7% and a 50.20% success rate on recommended stocks. In addition to Stifel Nicolaus, Proficient Auto Logistics, Inc. also received a Buy from William Blair's Ryan Merkel in a report issued on August 12. However, on August 14, TR | OpenAI – 4o reiterated a Hold rating on Proficient Auto Logistics, Inc. (NASDAQ: PAL). The company has a one-year high of $20.58 and a one-year low of $5.88. Currently, Proficient Auto Logistics, Inc. has an average volume of 179.3K. Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PAL in relation to earlier this year. Earlier this month, Amy F. Rice, the President & COO of PAL sold 6,100.00 shares for a total of $47,702.00.
Business Insider
43 minutes ago
- Business Insider
‘History Doesn't Favor the Bulls,' Says Top Investor About Palantir Stock
Palantir (NASDAQ:PLTR) stock has been on a tear – no secret there – with shares up nearly 450% over the past year. But the surge reflects more than just AI hype: revenues are rising quickly, new clients keep joining, and management has consistently raised its outlook. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In fact, the company recently crossed the $1 billion quarterly revenue milestone for the first time. While Palantir built its reputation on U.S. government security contracts, its latest results show momentum is spreading beyond that niche. U.S. commercial revenue jumped 93% year-over-year – clear evidence that businesses across the economy are finding enormous value in Palantir's expanding suite of AI tools. And Palantir doesn't seem to be taking its foot off the gas pedal. The company raised its Q3 revenue guidance to $1.087 billion, which would represent 50% year-over-year revenue growth. The biggest – and perhaps, only – knock against the company is its sky-high valuation. Seizing on this concern, top investor Julian Lin offers a word of caution. 'Despite stellar performance, I believe PLTR stock's valuation is in bubble territory, far exceeding historical tech bubbles,' explains the 5-star investor, who is among the top 1% of TipRanks' stock pros. There's one particular historical example that Lin mentions, which could cause PLTR bulls to start sweating. That would be Cisco, which was trading at 30x sales before it came crashing down during the 2000 stock bubble. PLTR was recently trading as high as 100x sales, reminds the investor. 'History has proven time and time again that valuations always end up mattering,' emphasizes Lin. As great as the company has been performing, Lin points out that PLTR's share price is already pricing in years of future growth. While this has arguably been the case for much of the past year, eventually the investor believes the bubble will pop. This will especially be the case when some negative catalysts enter the picture, which could come in the form of higher inflation or AI-related job losses. This could cause a massive re-rating for PLTR, which Lin suggests could reach a downside of some 80%. For that reason, the investor is getting out of dodge and is urging bulls to reconsider their commitment to PLTR. 'I just know that history does not shine well when valuations reach irrational exuberance. I reiterate my Strong Sell rating for the stock,' concludes Lin. (To watch Julian Lin's track record, click here) How does Wall Street see Palantir? The consensus view is less dramatic but hardly bullish. With 13 Hold ratings, 5 Buys, and 2 Sells, PLTR currently carries a consensus Hold (i.e., Neutral) rating. The Street's average 12-month price target of $154.56 implies ~11% downside from current levels. (See PLTR stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
an hour ago
- Yahoo
Blockchain Lender Figure Joins Crypto IPO Rush With Nasdaq Listing Bid Under 'FIGR'
Figure, the blockchain-powered lender founded by SoFi co-founder Mike Cagney, has filed with the Securities and Exchange Commission for an initial public offering as the latest entrant in a growing crypto IPO wave. The company plans to list its Class A shares on the Nasdaq under the ticker FIGR, with Goldman Sachs, Jefferies, and BofA Securities serving as lead underwriters. Figure's path to public markets has been years in the making. In 2021, it launched a special purpose acquisition company, Figure Acquisition Corp. I, with a $250 million raise aimed at acquiring growth-stage businesses using Provenance as an efficiency layer, however in the end this SPAC did not bring Figure to market. A friendlier regulatory stance under the Trump administration and buoyant crypto and stock markets have set the stage for a surge of digital asset firms tapping the equity markets, including crypto exchange Bullish which is the owner of CoinDesk. The company last month merged with Figure Markets, a blockchain marketplace also launched by Cagney that issues YDLS, a yield-bearing stablecoin structured as a tokenized money market fund. Financials disclosed in the S-1 show revenue up 22.4% in the first half of 2025 to $190.6 million, with net income of $29 million compared with a $13 million loss a year earlier. According to the filing with the SEC, proceeds from the IPO will fund working capital and potential acquisitions, with no dividends in to access your portfolio
